Collegium Pharmaceutical Inc (COLL) — Cash Flow-to-Debt Ratio
Collegium Pharmaceutical Inc (COLL) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of $78.44 Million could theoretically repay 0% of its total liabilities ($1.33 Billion) in one year. See Collegium Pharmaceutical Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Collegium Pharmaceutical Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Collegium Pharmaceutical Inc across 12 annual periods. For the full cash flow conversion analysis, see COLL operating cash flow.
Annual Cash Flow-to-Debt Ratio for Collegium Pharmaceutical Inc (2013–2024)
Year-by-year debt coverage analysis for Collegium Pharmaceutical Inc. Check cash flow quality index of Collegium Pharmaceutical Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | $204.98 Million | $1.43 Billion | ▼ -50.7% |
| 2023 | 0.29x | $274.75 Million | $947.88 Million | ▲ +128.5% |
| 2022 | 0.13x | $124.23 Million | $979.29 Million | ▼ -40.1% |
| 2021 | 0.21x | $103.56 Million | $489.15 Million | ▲ +3.2% |
| 2020 | 0.21x | $93.94 Million | $457.81 Million | ▲ +61.7% |
| 2019 | 0.13x | $27.78 Million | $218.87 Million | ▼ -85.0% |
| 2018 | 0.85x | $169.39 Million | $199.66 Million | ▲ +139.9% |
| 2017 | -2.13x | $-67.02 Million | $31.49 Million | ▲ +23.1% |
| 2016 | -2.77x | $-75.05 Million | $27.11 Million | ▼ -62.3% |
| 2015 | -1.71x | $-21.57 Million | $12.65 Million | ▼ -64.7% |
| 2014 | -1.04x | $-17.95 Million | $17.33 Million | ▲ +78.4% |
| 2013 | -4.79x | $-16.53 Million | $3.45 Million | — |